Moximed Raises $50M Series C from NEA

3/19/17

Moximed Inc, a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis, has raised $50 million in Series C funding. The company’s investors include Advent Life Sciences, Future Fund, NEA, Morgenthaler Ventures, GBS Venture Partners and Vertex Healthcare. In conjunction with the funding, Dr. Shahzad Malik, a general partner at Advent Life Sciences and Brigitte Smith, a managing director at GBS Venture Partners, have been added to Moximed’s board of directors.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect